Mr Atul Vasani, CMD, Vaishali Pharma Limited
MUMBAI, 28 FEBRUARY, 2023 (GPN): Mumbai based Vaishali Pharma Limited, leading supplier of pharmaceutical products to corporates, hospitals and retails stores has made its grasp on the overseas market and getting an excellent feedback worldwide. The Company is showing consistent agility and innovation by meeting the needs of its customers in both Domestic and International markets.
Vaishali Pharma Limited, continued to remain steadfast in it’s transformation journey, building additional pathways of growth and simultaneously focusing on making the organisation more efficient, They believe that the “Quality is an ongoing process of building and sustaining relationship.”
In business since 1989 The Company is amongst the leading players in the supply of pharma products – Bulk Drugs / APIs, Formulations, Surgical Products, Veterinary supplements, Herbal & Nutraceutical products, with a well-established brand known for its high-quality products & services amongst various clients globally. The company has over 250 + formulation brands marketed in multiple countries; of which dossier is in CTD format along with its respective bioequivalence. The company has built a robust pipeline of around 250 Dossiers. The Company’s synergistic collaboration with WHO-GMP manufacturing facilities is backed by an excellent rapport with clients.
Recently Vaishali Pharma Ltd received order s worth 73.85 Million USD (Approx Rs 600 Crores) with an overseas buyer for purchase of Antibiotics Pharmaceutical products. This is the result of correspondence with them since last 6 months.
Mr Atul Vasani, CMD, Vaishali Pharma Limited, said, “We are happy to share the news of receiving this valuable order, This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months. As per our Company’s policy we have done the Due diligence and respective contracts with the overseas Company. We have discussed various prospects with the company for the long term relations and also we look forward to achieve more orders from them,”
He added, “Quality being the primary goal of our association, is the Strength of our Partnership. We have strong foothold in sourcing various products in India. Wherein Vaishali Pharma, is a 30 years old pharmaceutical organization, entirely involved in International Business Marketing of Pharmaceutical Products; along with Nutraceutical Products for Domestic and International Market.”
“The company is showing consistent agility and innovation by meeting the needs of its customers in both domestic and international markets. We continue to remain steadfast in our transformation journey, building additional pathways of growth and simultaneously focusing on making the organisation more efficient,” the management said.
Vaishali Pharma is engaged in the supply of pharmaceutical products to corporates, hospitals and retails stores in India and abroad. The company is a leading global player in the supply of pharma products, including bulk drugs, APIs, formulations, surgical products, veterinary supplements as well as herbal and nutraceutical products.
The company has more than 250 formulation brands marketed in multiple countries.
According to the drug manufacturer, its international associations are entirely backed by the quality norms adhered to for all products and this will help the company to achieve new milestones. Ends
Be the first to comment on "Vaishali Pharma Receives Rs 600 Cr Order from Overseas Buyers"